Applicability of ashortened interpretation model for intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism in an endemic goiter region

被引:5
|
作者
Riss, Philipp [1 ]
Geroldinger, Angelika [2 ]
Selberherr, Andreas [1 ]
Brammen, Lindsay [1 ]
Heidtmann, Julian [1 ]
Scheuba, Christian [1 ]
机构
[1] Med Univ Vienna, Sect Endocrine Surg, Div Gen Surg, Dept Surg, Waehringer Guertel 18-20, A-1090 Vienna, Austria
[2] Med Univ Vienna, Sect Clin Biometr, Ctr Med Stat Informat & Intelligent Syst CeMSIIS, Vienna, Austria
来源
EUROPEAN SURGERY-ACTA CHIRURGICA AUSTRIACA | 2018年 / 50卷 / 05期
关键词
Primary hyperparathyroidism; Intraoperative parathyroid hormone monitoring; Vienna criterion; Parathyroid surgery; Surgery; MINIMALLY INVASIVE PARATHYROIDECTOMY; PTH SPIKES; BASE-LINE; ASSAY; SURGERY; EXPLORATION; CRITERIA; DISEASE;
D O I
10.1007/s10353-018-0547-8
中图分类号
R61 [外科手术学];
学科分类号
摘要
BackgroundIn primary hyperparathyroidism (pHPT), quick intraoperative parathyroid hormone monitoring (IOPTH) is performed to predict complete excision of hyperfunctioning tissue and therefore cure. In recent years, efforts have been made to make this prediction more accurate and to shorten the duration of the test, respectively, and therefore reduce waiting and total operating time. The aim of this study was to evaluate the practicability and safety of atime-reduced criterion (decline35% after 5min) in alarge cohort of patients.MethodsIn an 11-year period, all patients operated for pHPT were analyzed. After preoperative localization studies, hyperfunctioning parathyroid tissue was removed and IOPTH monitoring was performed. Intraoperatively, adecline of 50% from baseline 10min after excision of the gland predicted cure. The performance of an interpretation model, using an earlier PTH level was analyzed retrospectively (decline35% from baseline 5min after excision). Differences in sensitivity, specificity, positive/negative predictive value and accuracy were calculated.ResultsAccording to the inclusion criteria, 1018 patients were analyzed. IOPTH predicted cure in 854 patients (83.9%) 10min after gland excision with afalse positive decline in 13patients (1.5%). Applying the modified criterion (35% decline within 5min), 814 patients (80%) showed an appropriate decline (false positive in 18 [2.2%]). Overall, multiple gland disease would have been missed in 7patients. McNemar's test showed asignificantly lower sensitivity, specificity and accuracy applying the 35% criterion.ConclusionsIn an endemic goiter region, acriterion, demanding a35% decline 5min after excision can not be recommended for IOPTH monitoring in patients with pHPT.
引用
收藏
页码:228 / 231
页数:4
相关论文
共 50 条
  • [21] Contemporary surgical treatment of primary hyperparathyroidism without intraoperative parathyroid hormone measurement
    Mownah, O. A.
    Pafitanis, G.
    Drake, W. M.
    Crinnion, J. N.
    ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2015, 97 (08) : 603 - 607
  • [22] Successful parathyroidectomy guided by intraoperative parathyroid hormone monitoring for primary hyperparathyroidism is preserved in mild and moderate renal insufficiency
    Marcadis, Andrea R.
    Teo, Richard
    Ouyang, Wenqi
    Farra, Josefina C.
    Lew, John I.
    SURGERY, 2018, 163 (03) : 633 - 637
  • [23] Minimally invasive surgery for primary hyperparathyroidism with or without intraoperative parathyroid hormone monitoring
    Sugino, Kiminori
    Ito, Koichi
    Nagahama, Mitsuji
    Kitagawa, Wataru
    Shibuya, Hiroshi
    Ohkuwa, Keiko
    Yano, Yukiko
    Ito, Kunihiko
    ENDOCRINE JOURNAL, 2010, 57 (11) : 953 - 958
  • [24] Preoperative matching studies in the diagnosis of parathyroid adenoma for primary hyperparathyroidism: Can we avoid intraoperative PTH monitoring?
    Laxague, Francisco
    Agustin Angeramo, Cristian
    Dante Armella, Enrique
    Cesar Valinoti, Agustin
    Aristides Mezzadri, Norberto
    Fernandez Vila, Juan Manuel
    CIRUGIA ESPANOLA, 2021, 99 (08): : 572 - 577
  • [25] The Value of Intraoperative Parathyroid Hormone Monitoring in Localized Primary Hyperparathyroidism: A Cost Analysis
    Lilah F. Morris
    Kyle Zanocco
    Philip H. G. Ituarte
    Kevin Ro
    Quan-Yang Duh
    Cord Sturgeon
    Michael W. Yeh
    Annals of Surgical Oncology, 2010, 17 : 679 - 685
  • [26] Is intraoperative parathyroid hormone monitoring necessary for primary hyperparathyroidism with concordant preoperative imaging?
    Bobanga, Iuliana D.
    McHenry, Christopher R.
    AMERICAN JOURNAL OF SURGERY, 2017, 213 (03) : 484 - 488
  • [27] Intraoperative Parathyroid Hormone Assay in Patients With Primary Hyperparathyroidism and Double Adenoma
    Kandil, Emad
    Alabbas, Haytham H.
    Bansal, Anshuman
    Islam, Tareq
    Tufaro, Anthony P.
    Tufano, Ralph P.
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2009, 135 (12) : 1206 - 1208
  • [28] Cost-benefit analysis of the intraoperative parathyroid hormone assay in primary hyperparathyroidism
    Badii, Benedetta
    Staderini, Fabio
    Foppa, Caterina
    Tofani, Lorenzo
    Skalamera, Ileana
    Fiorenza, Giulia
    Qirici, Eva
    Cianchi, Fabio
    Perigli, Giuliano
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2017, 39 (02): : 241 - 246
  • [29] Intraoperative Parathyroid Hormone Monitoring in Parathyroidectomy for Tertiary Hyperparathyroidism
    Ermer, Jae P.
    Kelz, Rachel R.
    Fraker, Douglas L.
    Wachtel, Heather
    JOURNAL OF SURGICAL RESEARCH, 2019, 244 : 77 - 83
  • [30] Primary hyperparathyroidism with normal baseline intraoperative parathyroid hormone: A challenging population
    Javid, Mahsa
    Callender, Glenda
    Quinn, Courtney
    Carling, Tobias
    Donovan, Patricia
    Udelsman, Robert
    SURGERY, 2017, 161 (02) : 493 - 498